Background: The posterior cingulate cortex (PCC) is a metabolic hub within the default-mode network and an early target of Alzheimer's disease (AD) pathology, yet its quantitative relationship with cognition across the normal aging–mild cognitive impairment (MCI)–AD continuum remains incompletely defined. Objective: In this study we aimed to compare PCC volumes across AD, MCI, and controls, and assess their relationship with cognitive performance. Methods: In this single-center cross-sectional study, 161 participants (NL = 30, MCI = 60, AD = 71) underwent structural MRI. PCC volumes were automatically segmented and summed. Linear regressions adjusted for age and sex were performed to examine associations between PCC volumes and cognitive measures. False discovery rate correction was applied to multiple comparisons. Additional subgroup analyses were conducted by gender and education level using Mann–Whitney U tests, and ordinary least squares regression models tested for group × education interactions. Results: Mean Post-cin-T volume declined step-wise from NL (6.05 ± 0.21cm 3 ) to MCI (5.64 ± 0.63cm 3 ) to AD (4.98 ± 1.01cm 3 ; p < 0.001). Post-cin-R and Post-cin-L showed parallel gradients. Higher MoCA scores correlated with larger PCC volumes (e.g., total: β = 0.069, p < 0.001), whereas higher CDR scores were linked to smaller volumes (total: β = –0.705, p < 0.001). Subgroup analyses revealed that higher-education participants showed broader PCC–cognition associations. Interaction analyses indicated no significant moderating effect of education on group–volume relationships. Conclusions: Quantitative PCC atrophy differentiates NL, MCI and AD and correlates robustly with cognitive performance, particularly in educated individuals. PCC volumetry may serve as a non-invasive MRI biomarker for early diagnosis and disease staging in the AD spectrum.
To perform CT-angiography of coronary arteries, energy-integrating detector computed tomography (EID-CT) is widely used but it has several limitations, esp
16 October 2024 in Psychiatry and Clinical Neurosciences Reports
Aim: To explore white matter (WM) tracts linked to impulsivity using the diffusion magnetic resonance imaging (DMRI) connectometry method.Methods: We analyzed 218 healthy participants from the Leipzig Study for Mind‐Body‐Emotion Interactions database. Impulsivity correlations with DMRI‐derived WM changes were assessed using Urgency‐Premeditation‐Perseverance‐Sensation (UPPS) Impulsive Behavior Scale subscales: lack of perseverance (PE), lack of premeditation (PM), sensation seeking (SS), and negative urgency. DMRI data were processed using connectometry, adjusting for sex and age, to examine WM tract integrity via quantitative anisotropy (QA). Also, two additional interaction analyses were conducted to separately examine the interaction effect between WM QA, and sex and age in predicting impulsive behavior scores. The significance level in our statistical analyses was set at a false discovery rate (FDR) below 0.05.Results: QA in the bilateral cerebellum and middle cerebellar peduncle showed a negative association with PE and PM severity (FDR = 0.0004). QA in the middle cerebellar peduncle, corpus callosum body, and forceps major demonstrated a positive association with SS (FDR = 0.0001). Conversely, QA in forceps minor had a positive association with PM (FDR = 0.004), and QA in forceps minor and bilateral cingulum showed a positive association with SS (FDR = 0.0005). Age and sex had no significant effects on the association between WM QA and UPPS subscale scores.Conclusion: Impulsivity is linked to distinct WM integrity changes in various tracts, including the corpus callosum, cerebellum, and cingulum, offering insights into the pathophysiology of impulsivity and guiding future research.
Background: Neurological disorders impose a significant health burden globally, particularly in regions like North Africa and the Middle East (NAME) with unique healthcare and societal challenges. Despite progress in addressing neurological conditions, understanding the burden in pediatric and adolescent populations remains limited. This study analyzes the trends and burden of neurological conditions in individuals under 20 years old across the NAME super region from 1990 to 2021 using Global Burden of Disease (GBD) data. Methods: GBD 2021 data were analyzed to assess prevalence, incidence, years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life years (DALYs), and mortality rates. The data were stratified by age, sex, and sociodemographic index (SDI). Population attributable fraction was used to estimate the burden attributable to risk factors, and uncertainty intervals (UIs) were calculated using 500 posterior draws, reporting 95% UIs based on the 2.5th and 97.5th percentiles. All visualizations and analyses were conducted using Python (version 3.12.4). Results: Neurological condition prevalence in 2021 was 21,797.5 per 100,000, with tension-type headaches and migraines accounting for the majority of cases. Idiopathic epilepsy remained a leading cause of mortality, although it had a decrease of −50.9% in YLLs compared to 1990. Migraine affected about 9,161.9 per 100,000, increasing by 9.9% from 1990. It also accounted for the highest YLD rate (350.9). Despite decreases in YLLs and deaths, YLDs showed minimal change. Similarly, DALYs did not show significant change from 1990 (17.9%; 95% UI: −12.17 to 36.05). Higher SDI was associated with reduced DALYs but increased prevalence and YLDs. Conclusion: The burden of neurological disorders in pediatric and adolescent populations in NAME highlights regional disparities and the need for targeted healthcare strategies. Enhanced screening, early diagnosis, and management are essential to reducing the burden of these disorders.
5 April 2026 in Psychiatry and Clinical Neurosciences
Percutaneous sclerotherapy with bleomycin is an effective, minimally invasive treatment for aggressive pediatric hemangiomas, especially when traditional therapies fail. This approach can improve clinical outcomes, including thrombocytopenia resolution and tumor size reduction, with minimal systemic side effects.